Q1 2025 Oriola Oyj Earnings Call Transcript

Apr 29, 2025 / 07:00AM GMT

Release Date Price: €1.02

Transcript

Key Points

Positve

Oriola Corp (FRA:O5O) reported a strong net sales growth of 19% in Q1 2025, with organic growth at 8%.
The sales margin improved to EUR 41.3 million, supported by the distribution segments.
Customer satisfaction reached an all-time high in both countries, indicating strong customer relations.
The acquisition of MedInfo in Denmark expands Oriola's Nordic footprint in advisory services.
Kronans Apotek, a joint venture, achieved double-digit growth in the e-commerce sector and increased market share in physical pharmacies.

Negative

Adjusted EBITDA declined due to higher costs, particularly in the wholesale segment.
The pharmaceutical market in Finland showed a decline, impacting sales negatively.
Challenges in medicine availability persist in Europe, with no immediate improvement expected.
The unfavorable product mix in the wholesale segment led to a decline in profitability.
The ERP project incurred significant costs, impacting the financial results.

Tua Stenius;Ornhjelm

Oriola Oyj - Investor Relations and Sustainability Manager

Good morning everyone, and a warm welcome to Oriola's Q1 results webcast.

My name is Tua Stenius Ornhjelm, and I am from Oriola Investor Relations with me today I have our CEO Katarina Gabrielson and CFO Mats Danielsson.

(Operator Instructions)

And without further ado, I would like to hand over to Katarina.

Katarina Gabrielson

Oriola Oyj - President, Chief Executive Officer, Member of the Group Management Team

Thank you. This is the agenda for today. This is a quite traditional agenda that we have in these webcasts. We will start with the highlights, then the operating environment, segments, and then we will talk about the financial review before we come to the Q&As.

Starting with the highlights of the first quarter. I'm really happy to see that to be able to see that we have a steady growth and also progress towards the long-term goals that we have. The net sales in 2025 ended up at EUR447 million. It's 19% growth. The

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.